Biophysics in Drug Discovery 2016
Developing the Synergy between Biophysics and Medicinal Chemistry to Deliver Better Drugs
Strasbourg, France June 7-10, 2016
Bristol-Myers-Squibb, Princeton, United States
GlaxoSmithKline, Stevenage, United Kingdom
Uppsala University, Uppsala, Sweden
Bayer, Berlin, Germany
leadXpro, Villigen, Switzerland
AstraZeneca, Macclesfield, United Kingdom
University of York & Vernalis, Cambridge, United Kingdom
Philipps-University Marburg, Marburg, Germany
Boehringer Ingelheim, Biberach, Germany
Novartis Institute of Biomedical Research, Basel, Switzerland
NovAliX & Ribostruct, Illkirch, France